These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Pathogenesis of contrast-induced nephropathy: experimental and clinical observations with an emphasis on the role of osmolality. Rudnick MR; Goldfarb S Rev Cardiovasc Med; 2003; 4 Suppl 5():S28-33. PubMed ID: 14668707 [TBL] [Abstract][Full Text] [Related]
23. Contrast nephropathy in patients with impaired renal function: high versus low osmolar media. Barrett BJ; Parfrey PS; Vavasour HM; McDonald J; Kent G; Hefferton D; O'Dea F; Stone E; Reddy R; McManamon PJ Kidney Int; 1992 May; 41(5):1274-9. PubMed ID: 1614041 [TBL] [Abstract][Full Text] [Related]
24. Impact of iso-osmolar versus low-osmolar contrast agents on contrast-induced nephropathy and tissue reperfusion in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the Contrast Media and Nephrotoxicity Following Primary Angioplasty for Acute Myocardial Infarction [CONTRAST-AMI] Trial). Bolognese L; Falsini G; Schwenke C; Grotti S; Limbruno U; Liistro F; Carrera A; Angioli P; Picchi A; Ducci K; Pierli C Am J Cardiol; 2012 Jan; 109(1):67-74. PubMed ID: 21943940 [TBL] [Abstract][Full Text] [Related]
25. Iodinated contrast media and the kidney. Weisbord SD Rev Cardiovasc Med; 2008; 9 Suppl 1():S14-23. PubMed ID: 18418313 [TBL] [Abstract][Full Text] [Related]
26. Nephrotoxicity of contrast media in high-risk patients with renal insufficiency: comparison of low- and high-osmolar contrast agents. Deray G; Bellin MF; Boulechfar H; Baumelou B; Koskas F; Baumelou A; Grellet J; Jacobs C Am J Nephrol; 1991; 11(4):309-12. PubMed ID: 1799190 [TBL] [Abstract][Full Text] [Related]
27. Gadolinium contrast media are more nephrotoxic than a low osmolar iodine medium employing doses with equal X-ray attenuation in renal arteriography: an experimental study in pigs. Elmståhl B; Nyman U; Leander P; Chai CM; Frennby B; Almén T Acad Radiol; 2004 Nov; 11(11):1219-28. PubMed ID: 15561568 [TBL] [Abstract][Full Text] [Related]
28. Miscellaneous adverse effects of low-versus high-osmolality contrast media: a study revised. Brismar J; Jacobsson BF; Jorulf H Radiology; 1991 Apr; 179(1):19-22. PubMed ID: 1826061 [TBL] [Abstract][Full Text] [Related]
29. The protective role of telmisartan against nephrotoxicity induced by X-ray contrast media in rat model. Duan SB; Wang YH; Liu FY; Xu XQ; Wang P; Zou Q; Peng YM Acta Radiol; 2009 Sep; 50(7):754-9. PubMed ID: 19452295 [TBL] [Abstract][Full Text] [Related]
30. Nephrotoxicity of high- and low-osmolality contrast media. Jevnikar AM; Finnie KJ; Dennis B; Plummer DT; Avila A; Linton AL Nephron; 1988; 48(4):300-5. PubMed ID: 3362276 [TBL] [Abstract][Full Text] [Related]
31. Nephrotoxicity from contrast material in renal insufficiency: ionic versus nonionic agents. Harris KG; Smith TP; Cragg AH; Lemke JH Radiology; 1991 Jun; 179(3):849-52. PubMed ID: 2028004 [TBL] [Abstract][Full Text] [Related]
32. Iodixanol versus low-osmolar contrast media for prevention of contrast induced nephropathy: meta-analysis of randomized, controlled trials. From AM; Al Badarin FJ; McDonald FS; Bartholmai BJ; Cha SS; Rihal CS Circ Cardiovasc Interv; 2010 Aug; 3(4):351-8. PubMed ID: 20647563 [TBL] [Abstract][Full Text] [Related]
33. Contrast media nephrotoxicity: comparison of diatrizoate, ioxaglate, and iohexol after intravenous and renal arterial administration. Koutsikos D; Konstadinidou I; Mourikis D; Rizos D; Kapetanaki A; Agroyannis B; Vlachos L Ren Fail; 1992; 14(4):545-54. PubMed ID: 1462006 [TBL] [Abstract][Full Text] [Related]
34. Haemodynamic effects of water-soluble contrast media on the isolated perfused rat kidney. el Sayed AA; Haylor JL; el Nahas AM; Salzano S; Morcos SK Br J Radiol; 1991 May; 64(761):435-9. PubMed ID: 2036568 [TBL] [Abstract][Full Text] [Related]
35. Contrast-induced acute kidney injury in patients with renal dysfunction undergoing a coronary procedure and receiving non-ionic low-osmolar versus iso-osmolar contrast media. Alexopoulos E; Spargias K; Kyrzopoulos S; Manginas A; Pavlides G; Voudris V; Lerakis S; McLean DS; Cokkinos DV Am J Med Sci; 2010 Jan; 339(1):25-30. PubMed ID: 19996728 [TBL] [Abstract][Full Text] [Related]
36. Ionic low-osmolar versus nonionic iso-osmolar contrast media to obviate worsening nephropathy after angioplasty in chronic renal failure patients: the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) study. Mehran R; Nikolsky E; Kirtane AJ; Caixeta A; Wong SC; Teirstein PS; Downey WE; Batchelor WB; Casterella PJ; Kim YH; Fahy M; Dangas GD JACC Cardiovasc Interv; 2009 May; 2(5):415-21. PubMed ID: 19463464 [TBL] [Abstract][Full Text] [Related]
37. Cost-effectiveness of iso- versus low-osmolality contrast media in outpatients with high risk of contrast medium-induced nephropathy. Chicaíza-Becerra LA; García-Molina M; Gamboa Ó Biomedica; 2012 Jun; 32(2):182-8. PubMed ID: 23242291 [TBL] [Abstract][Full Text] [Related]
38. Nephrotoxicity of high and low osmolar contrast media: case control studies following digital subtraction angiography in potential risk patients. Scherberich JE; Fischer A; Rautschka E; Kollath J; Riemann H Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():91-4. PubMed ID: 2568816 [TBL] [Abstract][Full Text] [Related]
40. The role of osmolality in the incidence of contrast-induced nephropathy: a systematic review of angiographic contrast media in high risk patients. Solomon R Kidney Int; 2005 Nov; 68(5):2256-63. PubMed ID: 16221227 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]